Merger Roundup: August 26, 2013 - Presented by: The Aol. On Network

Amgen (AMGN) and Onyx Pharmaceuticals (ONXX) announced they have approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 billion, or $9.7 billion net of estimated Onyx cash.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.56 0.12 ▲ 0.73%
VALE $ 8.455 0.43 ▲ 5.29%
PBR $ 10.3251 0.55 ▲ 5.57%
BABA $ 78.46 2.13 ▼ 2.64%
AAPL $ 127.02 1.68 ▼ 1.31%
QQQ $ 108.27 0.96 ▼ 0.88%
VALE/P $ 6.55 0.27 ▲ 4.30%
MSFT $ 48.04 0.20 ▼ 0.41%

As of 5/5/2015, 10:38 AM